Selection of blockbuster announcements

1、$Geely Automobile (00175.HK) $December sales of new energy vehicles increased by about 162% compared with the same period last year. Total sales of 2021 reached 1.328 million.

Geely Automobile announced that car sales in December were 158765, up 3% from a year earlier and 17% from a month earlier, while sales of new energy vehicles in December were 18813, up about 162% from a year earlier. Total sales in 2021 were 1.328 million vehicles, an increase of about 1 per cent year-on-year and 87 per cent of the sales target for 2021, and the sales target for 2022 was 1.65 million vehicles, an increase of about 24 per cent over the total sales achieved in 2021.

2、$Tencent (00700.HK) $Repurchase of 470000 shares at a cost of about HK $202.7 million

Tencent announced that it would buy back 470000 shares at a price range of HK $421-HK $436.8 on January 6, at a total cost of about HK $202.7 million.

3、$DongFeng Motor Group (00489.HK) $Sales target for 2022 is 3.471 million vehicles, an increase of 25% over 2021

Dongfeng Group announced that based on the prediction of the development of the Chinese automobile market in 2022 and the development trend of the group, the board of directors initially set the group's sales target of 3.471 million vehicles in 2022, an increase of 25 per cent compared with 2021. Of these, passenger car sales target is 2.894 million, up 28% from 2021, while commercial vehicle sales are targeted at 577000, up 10% from 2021.

4、$Nuohui Health-B (06606.HK) $Application for registration of ®for Helicobacter pylori consumer self-test product approved by the State Drug Administration

Nuohui Health-B issued an announcement that on January 6, 2022, the company received a notice from the State Drug Administration.^®Approval of an application for registration as a Class III medical device. Secluded tube^®For the company based on fecal samples to detect Helicobacter pylori gastric cancer screening consumer self-test products. Helicobacter pylori is the main carcinogenic factor of gastric cancer. The secluded tube independently developed by the company^®It is the first consumer self-test product of Helicobacter pylori approved by the State Drug Administration, and realizes the integrated design of sampling and testing. It is easy for consumers to use, there is no need to take medicine or fasting before testing, and there are no special requirements for sampling.

5、$Great Wall Motor (02333.HK) $Sales of 137000 new energy vehicles in 2021

Great Wall Motor announced that total sales in December were 162369, up 8.17% from a year earlier, while sales for the whole year were 1.28 million, up 15.24% from a year earlier. 22354 new energy vehicles were sold in December, and a total of 136953 were sold from January to December.

6、$remittance Technology (01860.HK) $Mintegral platform revenue in the fourth quarter was 190.5 million US dollars, an increase of 256.34% over the same period last year.

Huilun Technology announced that in the fourth quarter of 2021, the group's Mintegral platform recorded revenue of US $190.5 million, an increase of 256.34% over the fourth quarter of 2020 and 19.04% from the third quarter of 2021. Compared with the third quarter of 2021, the retention rate of advertisers is 84.61%, the growth of new advertisers is 22.36%, the retention rate of traffic publishers is 92.0%, the growth of new traffic publishers is 16.06%, and the number of traffic APP is 27.52%.

7、$BeiGene, Ltd. (06160.HK) $The China Drug Administration approved Bai Ze'an ®for second or third line therapy in patients with locally advanced or metastatic non-small cell lung cancer.

BeiGene, Ltd. announced that China's State Drug Administration (NMPA) has approved BeiGene, Ltd. 's anti-PD-1 antibody drug Bai Ze'an.®Tirelizumab injection is used for second or third line therapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). In March 2021, NMPA accepted the application for listing of the new indication (sBLA).

• Important matters

Shisiyao Group (02005): fluconazole Sodium Chloride injection obtained Drug Registration approval

Fosun (02196): tranexamic acid injection was accepted by the State Drug Administration for drug registration evaluation.

Zai Lab Limited-SB (09688): announced that the application for marketing of a new drug used in the treatment of breast cancer in China has been accepted by the State Drug Administration.

Smoore International Holdings Limited (06969): purchased a total of 3 billion yuan Bank of China Ltd. structural deposits

Yihe Holdings (00838): investment in the second phase of the Mexican industrial park was successfully completed.

Xingke Rong Medicine (06833): fully supported by Chengdu Tianfu International Biological City Management Committee for the project of Intelligent Medical and Beauty Industrial Park.

Trend in China (03818): concluding a Brand license Agreement on the "Kappa Kids" trademark

Honghua Group (00196): Sichuan Honghua will sell desert towing fast-moving drilling rigs and related parts to NDSC for a total of about 52 million US dollars.

JD Health (06618): several promotional services will be provided to JD.com Group.

Easy bulk (01733): adoption of the 2022 restricted share unit plan

• Financial report data

Hopson Development (00754): total contract sales of HK $51.736 billion rose 21.51% over the same period last year.

China overseas Hongyang Group (00081): contract sales of 71.204 billion yuan in 2021 increased by 10% over the same period last year.

CGN Power Co.,Ltd. (01816); total generating capacity of nuclear power units in 2021 is about 213.837 billion kWh, an increase of 7.8% over the same period last year.

Zhengrong Real Estate (06158): contract sales in 2021 increased by about 2.64% year-on-year to 145.643 billion yuan

China Overseas Land & Investment (00688): contract property sales in 2021 increased by 2.4% to 369.495 billion yuan.

China Jinmao (00817): cumulative contracted sales of 235.603 billion yuan in 2021 increased by 1.95% compared with the same period last year

Sino International (00732): year-on-year increase in consolidated net operating volume of about 1.9% to HK $22.586 billion in 2021

Shangkun Real Estate (06900): the contract sales in 2021 is about 24.84 billion yuan.

Qin Gang Stock (03369): the throughput of 2021 is about 379 million tons, an increase of 0.73% over the same period last year.

• Repurchase cancellation

Wuxi Biologics (02269): a total of 45.058 million shares were repurchased at a cost of HK $3.92 billion

XIAOMI Group-W (01810): repurchased 1.65 million shares at a cost of about HK $29.3674 million on January 6th

Easy bulk (01733): on January 6, it spent about HK $21.8757 million to buy back 18.348 million shares.

Haohai Biotechnology (06826): repurchase 197100 shares with HK $10.156 million on January 6th

Beijing Holdings (00392): HK $8.42 million buyback 300000 shares on January 6th

Weimeng Group (02013): repurchased 1.133 million shares with an investment of HK $7.7399 million on January 6th

Ping An Healthcare And Technology (01833): repurchased 280000 shares with a capital of HK $7.093 million on January 6th

Federal Pharmaceutical (03933): buy back 1.382 million shares with an investment of about HK $6.0972 million on January 6th

Country Garden Services Holdings (06098): repurchased 121000 shares with a capital of HK $4.8147 million on January 6th

Fosun (00656): repurchased 500000 shares at a cost of about HK $4.1208 million on January 6th

Net Dragon (00777): HK $3.59 million buys back 200000 shares on January 6

Liwen Paper (02314): buy back 601000 shares at a cost of about HK $3.2458 million on January 6th

Fuzhikang Group (02038): repurchased 1.755 million shares with a capital of about HK $2.4156 million on January 6.

Sunac Services (01516): repurchased 300000 shares with an investment of about HK $2.01 million on January 6th

• Change of equity

Iron goods (01029): Stocken is no longer a shareholder of the company

Vobile group (03738): increased 800000 shares by Chairman Wang Yangbin

• Guaranteed loan

Zhengrong Real Estate (06158): affiliated with Bank of China Ltd. 's credit line of 9.14 billion yuan

Shanghai Fosun Pharmaceutical (02196): intends to provide guarantee for subsidiaries

• Listing of new shares

Shunfeng City (09699): bought 19.677 million shares at the end of the stable price period of the global offering

German Commercial Investment Services (02270): end of stable price period for partial exercise of over-allotment rights